EVEREST MED.LTD DL-0001 (6HN) — Tangible Net Worth Ratio
EVEREST MED.LTD DL-0001 (6HN) has a Tangible Net Worth Ratio of 34.8% as of June 2026. This metric is calculated by deducting intangible assets (€3.41 Billion) from net assets (€5.23 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 6HN net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
EVEREST MED.LTD DL-0001 Tangible Net Worth Ratio (2021–2025)
This chart shows how EVEREST MED.LTD DL-0001's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 34.8%, reflecting net assets of €5.23 Billion with intangible assets of €3.41 Billion EUR. For live market cap and overall valuation, see 6HN market cap overview.
Annual Tangible Net Worth Ratio for EVEREST MED.LTD DL-0001 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for EVEREST MED.LTD DL-0001 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See EVEREST MED.LTD DL-0001 free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 60.0% | €5.30 Billion | €2.12 Billion | €6.83 Billion | ▲ +16.1 pp |
| 2024 | 43.9% | €4.07 Billion | €2.29 Billion | €4.96 Billion | ▼ -4.7 pp |
| 2023 | 48.5% | €4.97 Billion | €2.56 Billion | €5.77 Billion | ▼ -8.8 pp |
| 2022 | 57.3% | €5.65 Billion | €2.41 Billion | €6.61 Billion | ▲ +5.7 pp |
| 2021 | 51.6% | €5.89 Billion | €2.85 Billion | €6.65 Billion | — |